Syneos Health, Inc.

NasdaqGS:SYNH 株式レポート

時価総額:US$4.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Syneos Health マネジメント

マネジメント 基準チェック /14

Syneos Health'sの CEO はMichelle Keefeで、 Apr2022年に任命され、 の在任期間は 1.42年です。 の年間総報酬は$ 8.89Mで、 9.7%給与と90.3%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.034%を直接所有しており、その価値は$ 1.53M 。経営陣と取締役会の平均在任期間はそれぞれ2.7年と2.3年です。

主要情報

Michelle Keefe

最高経営責任者

US$8.9m

報酬総額

CEO給与比率9.7%
CEO在任期間1.4yrs
CEOの所有権0.03%
経営陣の平均在職期間2.7yrs
取締役会の平均在任期間2.3yrs

経営陣の近況

Recent updates

Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Mar 29
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?

Mar 10
Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?

Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?

Feb 20
Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?

Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?

Dec 20
Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?

Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?

Nov 28
Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?

Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors

Nov 01
Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors

Syneos, Datavant expand partnership on data analytics for clinical trials

Oct 11

Syneos Health falls 13% after update on outlook

Sep 13

When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?

Sep 08
When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?

Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Aug 22
Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Syneos Health Q2 2022 Earnings Preview

Aug 01

With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case

Jul 19
With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case

Syneos: Upside Could Be Priced In, Valuations Unsupportive

Jul 15

Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?

Jun 18
Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?

Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Jun 03
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt

May 19
We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt

Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?

Apr 08
Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?

Syneos Health: Upside Opportunity After Unexpected Correction In CRO Market, M&A Rumors

Mar 27

Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?

Mar 05
Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?

Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Feb 18
Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?

Feb 03
Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?

With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting

Jan 04
With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting

Syneos Health's Double-Digit Revenue Growth Sets The Tone For A Strong 2022

Dec 03

Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Dec 03
Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?

CEO報酬分析

Syneos Health の収益と比較して、Michelle Keefe の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2023n/an/a

US$71m

Mar 31 2023n/an/a

US$148m

Dec 31 2022US$9mUS$862k

US$266m

Sep 30 2022n/an/a

US$287m

Jun 30 2022n/an/a

US$278m

Mar 31 2022n/an/a

US$242m

Dec 31 2021US$2mUS$567k

US$235m

Sep 30 2021n/an/a

US$251m

Jun 30 2021n/an/a

US$236m

Mar 31 2021n/an/a

US$198m

Dec 31 2020US$2mUS$522k

US$193m

Sep 30 2020n/an/a

US$192m

Jun 30 2020n/an/a

US$187m

Mar 31 2020n/an/a

US$195m

Dec 31 2019US$2mUS$550k

US$131m

報酬と市場: Michelleの 総報酬 ($USD 8.89M ) は、 US市場 ($USD 6.76M ) の同規模の企業の平均を上回っています。

報酬と収益: Michelleの報酬は 20% 以上増加しましたが、会社の収益は過去 1 年間で 20% 以上減少しました。


CEO(最高経営責任者

Michelle Keefe (56 yo)

1.4yrs

在職期間

US$8,889,996

報酬

Ms. Michelle Keefe serves as Chief Executive Officer at Syneos Health, Inc since April 29, 2022 and serves as its Director since 2022. She served as President of Medical Affairs and Commercial Solutions fo...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Michelle Keefe
CEO & Director1.4yrsUS$8.89m0.034%
$ 1.5m
Michael Brooks
Chief Operating Officer1.4yrsUS$6.04m0.018%
$ 810.0k
Jonathan Olefson
General Counsel & Corporate Secretary4.8yrsUS$3.52m0.014%
$ 617.4k
Christian Tucat
Chief Business Officer5yrsUS$2.62m0.011%
$ 502.0k
Jason Meggs
Consultantless than a yearUS$3.19m0.039%
$ 1.8m
Michael Bonello
Chief Financial Officerless than a yearデータなしデータなし
Donna Kralowetz
Senior VP of Finance & Chief Accounting Officer2.7yrsデータなし0.0029%
$ 130.6k
Baba Shetty
President of Technology & Data Solutions1.4yrsデータなしデータなし
Judith Ng-Cashin
Chief Scientific Officer7.5yrsデータなしデータなし
Larry Pickett
Chief Information & Digital Officer2.8yrsデータなしデータなし
Ronnie Speight
Senior Vice President of Investor Relationsno dataデータなしデータなし
Kristen Spensieri
Global Head of Corporate Communications & Marketing6.1yrsデータなしデータなし

2.7yrs

平均在職期間

52.5yo

平均年齢

経験豊富な経営陣: SYNHの経営陣は 経験豊富 であると考えられます ( 2.7年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Michelle Keefe
CEO & Director1.7yrsUS$8.89m0.034%
$ 1.5m
Kenneth Meyers
Independent Director6.9yrsUS$370.77k0.019%
$ 865.7k
William Klitgaard
Independent Directorless than a yearUS$182.56k0%
$ 0
Matthew Monaghan
Independent Director6.9yrsUS$322.77k0.019%
$ 850.1k
Alfonso Zulueta
Independent Director1.7yrsUS$351.39k0.0034%
$ 150.2k
John Dineen
Independent Chairman4.8yrsUS$483.27k0.022%
$ 972.7k
David Wilkes
Independent Director2.3yrsUS$308.52k0.0048%
$ 213.5k
Bernadette Connaughton
Independent Director3.8yrsUS$307.77k0.0096%
$ 426.2k
Barbara Bodem
Independent Director1.7yrsUS$369.53k0.0034%
$ 151.6k

2.3yrs

平均在職期間

60yo

平均年齢

経験豊富なボード: SYNHの 取締役会経験豊富 ではない ( 2.3年の平均在任期間) ため、新しい取締役会が必要であると考えられます。